Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. | Director | Common Stock | 51.6K | $128K | $2.48 | May 23, 2024 | Direct |
Esperion Therapeutics, Inc. | Director | Stock Option (right to buy) | 32.5K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics, Inc. | May 23, 2024 | 2 | $0 | 4 | May 24, 2024 | Director |
ESPR | Esperion Therapeutics, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
ESPR | Esperion Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
ESPR | Esperion Therapeutics, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |